This article was originally published in The Tan Sheet
Statin therapy to reduce low-density lipoprotein cholesterol is not associated with an increased risk of cancer, despite previous reports to the contrary, according to a study in the September issue of the Journal of the American College of Cardiology. Researchers led by Alawi Alsheikh-Ali, with the Institute for Clinical Research and Health Policy Studies found through a meta-analysis of 15 randomized controlled trials that "a relationship between on-treatment LDL-C levels and incident cancer was also observed in control populations not treated with statins." Therefore, statin-treated patients lower their LDL-C while maintaining similar risk of cancer as non-statin treated patients, according to the study
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.